A thyroid-stimulating hormone test measures TSH, the pituitary signal that tells the thyroid gland to make thyroid hormone. It is the most common first test for primary thyroid disease, but its meaning changes when the pituitary or hypothalamus is not functioning normally. In an intact pituitary-thyroid axis, high TSH usually points toward an underactive thyroid, while low TSH usually points toward an overactive thyroid. In central hypothyroidism, however, free T4 can be low while TSH is low, normal, or only mildly high. TSH alone may therefore miss the diagnosis. The reverse mismatch—high free T4 or free T3 with a TSH that is not suppressed—requires careful confirmation because assay interference, thyroid hormone resistance, medicine effects, and a rare TSH-secreting pituitary tumor can look similar. Results must be interpreted with free T4, symptoms, medicines, pregnancy status, recent illness, prior thyroid or pituitary treatment, and the laboratory’s own reference interval.
- TSH is a pituitary signal, not a thyroid hormone: it should usually be read with free T4 when pituitary disease is possible.
- High TSH with low free T4 usually indicates primary hypothyroidism: the thyroid is not responding adequately to stimulation.
- Low TSH with high free T4 or free T3 usually indicates primary hyperthyroidism: excess thyroid hormone suppresses pituitary TSH.
- Low free T4 with low, normal, or mildly high TSH can indicate central hypothyroidism: a “normal” TSH is inappropriate when free T4 is low.
- High thyroid hormones with nonsuppressed TSH are unusual: repeat testing and evaluation for interference, thyroid hormone resistance, or a TSH-secreting pituitary tumor may be needed.
- Reference ranges are context specific: age, pregnancy, acute illness, medicines, assay method, and treatment status can all shift interpretation.
Table of Contents
- How the pituitary-thyroid axis works
- Why a TSH test is ordered
- Preparation, timing, and interference
- Normal range and paired TSH–free T4 results
- Central hypothyroidism and pituitary disease
- Nonsuppressed TSH with high thyroid hormones
- Treatment monitoring and special situations
- Follow-up and urgent symptoms
How the pituitary-thyroid axis works
The hypothalamus, pituitary, and thyroid form a feedback system. The hypothalamus releases thyrotropin-releasing hormone, or TRH. TRH stimulates pituitary thyrotroph cells to release TSH. TSH travels through the bloodstream to the thyroid, where it promotes iodine uptake, thyroid hormone production, and gland growth.
The thyroid releases mostly thyroxine, or T4, and a smaller amount of triiodothyronine, or T3. Tissues convert T4 into active T3 as needed. Free T4 and free T3 are the unbound fractions available to tissues. Most circulating hormone is attached to proteins, so total T4 and total T3 can change when binding proteins change even if thyroid function is stable.
T4 and T3 feed back to the pituitary and hypothalamus. When free thyroid hormone falls, an intact pituitary increases TSH. When free thyroid hormone rises, TSH falls. Because the relationship is steep and logarithmic, a modest free T4 change can produce a much larger TSH change. This makes TSH sensitive for early primary thyroid dysfunction.
That sensitivity depends on an intact axis. A diseased pituitary may not release enough biologically effective TSH. The measured concentration can appear normal even though it is inadequate for the low free T4. Some abnormal TSH molecules are detected by the assay but stimulate the thyroid poorly. This is why TSH cannot be treated as a stand-alone “thyroid level” in people with known or suspected pituitary disease.
TSH also changes over the day. Concentrations tend to rise at night and fall during daytime hours. For most routine testing, this variation is small enough that strict timing is unnecessary, but consistent timing can help when following borderline results or adjusting treatment.
Why a TSH test is ordered
TSH is used to screen for, diagnose, and monitor thyroid dysfunction. It may be ordered for symptoms of low thyroid hormone, including fatigue, cold intolerance, constipation, dry skin, weight gain, slowed thinking, heavy menstrual periods, low mood, or a slow heart rate. It may also be ordered for symptoms of excess thyroid hormone, including heat intolerance, tremor, palpitations, weight loss, anxiety, sweating, frequent bowel movements, muscle weakness, or an irregular heartbeat.
Other common reasons include:
- Follow-up of an abnormal free T4, free T3, thyroid antibody, or newborn screen
- Monitoring levothyroxine or antithyroid treatment
- Evaluation of infertility, menstrual disturbance, or pregnancy-related thyroid risk
- Investigation of a goiter, thyroid nodule, or family history of thyroid disease
- Assessment before or during medicines that can affect thyroid function
- Evaluation after thyroid surgery, radioactive iodine, neck radiation, pituitary surgery, or cranial radiation
- Investigation of a pituitary mass, visual-field problem, or several pituitary hormone deficiencies
- Monitoring after treatment of a TSH-secreting pituitary tumor
In routine primary thyroid disease, a reflex testing system may measure free T4 only when TSH is outside the reference interval. Reflex testing is efficient for many patients, but it can fail when the pituitary-thyroid axis is abnormal. If a clinician suspects pituitary disease, both TSH and free T4 should be requested from the start.
A central hypothyroidism test panel may also include morning cortisol, ACTH, prolactin, LH, FSH, sex hormones, IGF-1, sodium, and other tests. This broader assessment matters because pituitary disorders rarely respect one laboratory line. Cortisol status deserves special attention before thyroid hormone is started in a person who might have ACTH deficiency.
TSH is not a direct measure of metabolism, body temperature, fatigue severity, or “optimal” thyroid function. Symptoms are important, but they are nonspecific. A diagnosis requires a coherent biochemical pattern and clinical context.
Preparation, timing, and interference
A TSH test uses a venous blood sample. Fasting is usually unnecessary unless other ordered tests require it. Water is generally allowed. Follow the laboratory’s instructions, especially if glucose, lipids, medication levels, or other fasting tests are being collected at the same visit.
Tell the clinician and laboratory about all medicines and supplements. Important examples include:
- Levothyroxine, liothyronine, desiccated thyroid, and combination thyroid products
- Antithyroid medicines such as methimazole or propylthiouracil
- Amiodarone, lithium, iodine-containing products, and some immune therapies
- Glucocorticoids, dopamine agonists, somatostatin analogues, and certain antiseizure medicines
- Estrogen-containing therapy, pregnancy hormones, and androgen treatment
- High-dose biotin supplements
Do not stop a prescribed drug without instructions. A clinician may standardize the timing of thyroid medicine relative to the blood draw. Free T4 can rise for several hours after a levothyroxine dose, while TSH changes much more slowly. For comparable follow-up, some practices collect blood before the daily dose; others use a consistent post-dose interval. Consistency is more useful than mixing approaches.
Biotin can interfere with some immunoassays and may create a pattern that resembles hyperthyroidism, often with falsely low TSH and falsely high free thyroid hormones. The effect depends on the analyzer, dose, and time since the last supplement. The laboratory can advise how long to withhold biotin when appropriate.
Heterophile antibodies, anti-reagent antibodies, thyroid hormone autoantibodies, abnormal binding proteins, and rare assay-specific effects can also produce discordant results. Suspicion rises when laboratory values are extreme but symptoms do not fit, when results change sharply between platforms, or when repeated tests violate normal feedback physiology.
Acute illness can temporarily lower TSH, free T3, and sometimes free T4 without primary thyroid disease. Recovery may produce a brief TSH rise. Testing during hospitalization should answer a specific clinical question because nonthyroidal illness can be difficult to distinguish from true disease.
Pregnancy requires trimester- and method-specific interpretation. Human chorionic gonadotropin can stimulate the thyroid and lower TSH, especially early in pregnancy. Binding proteins also rise, affecting total hormone concentrations and sometimes the performance of free hormone assays. Pregnancy-specific guidance is preferable to a general adult range.
Normal range and paired TSH–free T4 results
TSH is commonly reported in milli-international units per liter, which is numerically equivalent to micro-international units per milliliter. Many adult laboratories use a reference interval near 0.4 to 4.0 mIU/L, but cutoffs vary. Age, pregnancy, population iodine intake, assay calibration, and local laboratory policy all matter. The range printed on the report should be used.
A value within the interval is not automatically normal for every situation. If free T4 is below range, a normal TSH may be inappropriately low. Conversely, TSH can remain suppressed for weeks or months after treatment of severe hyperthyroidism even after free T4 improves.
| TSH | Free T4 | Common interpretation | Important cautions |
|---|---|---|---|
| High | Low | Overt primary hypothyroidism | Confirm context; severe illness and assay issues can occasionally confuse the picture |
| High | Normal | Subclinical primary hypothyroidism | Repeat testing, symptoms, antibodies, age, pregnancy, and degree of elevation guide management |
| Low | High | Overt primary hyperthyroidism or excessive thyroid hormone treatment | Free T3, medicines, thyroid antibodies, and imaging may identify the cause |
| Low | Normal | Subclinical hyperthyroidism, recovering illness, medicine effect, pregnancy, or delayed TSH recovery | Trend and clinical context are essential |
| Low, normal, or mildly high | Low | Central hypothyroidism is possible | Exclude nonthyroidal illness, medicine effects, and assay problems; assess other pituitary axes |
| Normal or high | High | Inappropriate TSH secretion or misleading measurement | First exclude assay interference, medicine timing, binding-protein disorders, and thyroid hormone resistance |
Free T3 is helpful when TSH is low and free T4 is normal but hyperthyroidism remains suspected. T3 can rise before T4 in some forms of hyperthyroidism. In hypothyroidism, free T3 is less useful because the body can preserve T3 until later, and illness affects it strongly.
Thyroid antibodies answer a different question. Thyroid peroxidase antibodies can support autoimmune thyroiditis; TSH-receptor antibodies can support Graves disease. They do not replace TSH and free T4 for current functional status. A broader thyroid function test panel is chosen according to the pattern rather than ordered indiscriminately.
Central hypothyroidism and pituitary disease
Central hypothyroidism occurs when the hypothalamus or pituitary does not provide adequate TSH stimulation. Free T4 is low, while TSH is low, normal, or sometimes mildly elevated. The TSH result is “inappropriately” low for the thyroid hormone level.
Causes include pituitary tumors, surgery, radiation, traumatic brain injury, pituitary apoplexy, postpartum pituitary infarction, inflammatory or infiltrative disease, hypothalamic lesions, and congenital genetic disorders. Some patients have isolated central hypothyroidism, but many have deficiencies of ACTH, gonadotropins, growth hormone, or vasopressin as well.
Symptoms resemble primary hypothyroidism: fatigue, cold intolerance, dry skin, constipation, slowed thinking, weight change, menstrual disturbance, low libido, and reduced exercise tolerance. Headache, vision changes, excessive thirst, low blood pressure, infertility, or failure to lactate may suggest broader pituitary involvement.
A single low free T4 is not enough. Clinicians consider:
- Whether the result is repeatedly low or falling over time
- Whether TSH is an appropriate response
- Acute illness, calorie restriction, and medicines that suppress TSH
- Assay interference or an unreliable free T4 method
- Prior pituitary surgery, radiation, tumor, trauma, or genetic risk
- Other pituitary hormones and pituitary MRI findings
Morning cortisol should be assessed before starting levothyroxine when ACTH deficiency is possible. Thyroid hormone increases cortisol clearance and metabolic demand. Giving it before treating unrecognized adrenal insufficiency can precipitate adrenal crisis.
Once treatment begins, free T4—not TSH—is the main biochemical guide. The usual aim is an appropriate free T4 concentration within the laboratory range, often above the midpoint, adjusted for age, symptoms, heart disease, pregnancy, and individual circumstances. TSH may become fully suppressed on adequate replacement and should not trigger an automatic dose reduction.
A person with pituitary disease should not be reassured by a “normal TSH” if free T4 is low or symptoms and other hormone results suggest central dysfunction. Likewise, a mildly high TSH does not always prove primary hypothyroidism because biologically weak TSH can accumulate in central disease.
Nonsuppressed TSH with high thyroid hormones
High free T4 or free T3 should normally suppress TSH. When TSH remains normal or high, the result is unusual and should be confirmed before pituitary imaging or treatment. Laboratory interference and medication timing are more common explanations than a TSH-secreting tumor.
The review usually starts with repeat TSH, free T4, and free T3, preferably after checking supplement and medicine use. A sample may be tested on a different assay platform. Total T4, total T3, binding-protein studies, equilibrium dialysis or another reference method, dilution studies, and antibody-blocking procedures may help identify interference.
Taking levothyroxine shortly before blood collection can raise free T4 while TSH still reflects the average exposure over prior weeks. Irregular adherence can produce a similar pattern: missed doses keep TSH high, followed by several doses before testing that raise free T4. Amiodarone and other medicines can alter hormone conversion and feedback.
Resistance to thyroid hormone beta is a genetic condition in which tissues and the pituitary respond less strongly to thyroid hormone. People may have high free thyroid hormones with nonsuppressed TSH, variable symptoms, family members with similar results, and no pituitary tumor. Genetic testing and specialist evaluation may be appropriate.
A TSH-secreting pituitary neuroendocrine tumor, often called a TSHoma or TSH-PitNET, is rare. It causes central hyperthyroidism: high free T4 and free T3 with TSH that is not appropriately suppressed. Symptoms may include palpitations, tremor, heat intolerance, weight loss, goiter, and atrial arrhythmia. A larger tumor may cause headache, vision loss, or other pituitary hormone abnormalities. Some tumors also secrete growth hormone or prolactin.
Evaluation may include pituitary MRI, alpha-subunit measurement, sex hormone-binding globulin, other pituitary hormones, visual fields, family history, and genetic testing for thyroid hormone resistance. Dynamic tests are used selectively in specialist centers. An incidental pituitary lesion must not be assumed to be the cause because small nonfunctioning lesions are relatively common.
Treatment of a confirmed TSH-secreting tumor usually centers on pituitary surgery. Somatostatin receptor ligands can lower TSH and thyroid hormones and may shrink the tumor. Antithyroid drugs or beta-blockers may control thyrotoxicosis around definitive treatment. Removing or ablating the thyroid without recognizing a TSHoma can worsen loss of feedback and allow tumor growth.
Treatment monitoring and special situations
For primary hypothyroidism treated with levothyroxine, TSH is usually the main monitoring test after the pituitary has had enough time to respond. Testing is commonly repeated about six to eight weeks after starting or changing a dose, although the exact interval may vary. Once stable, monitoring becomes less frequent. Pregnancy, major weight change, interacting medicines, malabsorption, and new symptoms may require earlier reassessment.
A high TSH during treatment can reflect too little hormone, missed doses, poor absorption, interactions with iron, calcium, antacids or certain foods, a change in product, or incorrect timing. A low TSH can reflect excessive replacement, but it may also remain suppressed during recovery from hyperthyroidism. Free T4 and clinical context prevent premature dose changes.
In central hypothyroidism, TSH should not direct dosing. Free T4 and symptoms are used because the pituitary signal is unreliable. This difference is central to thyroid hormone replacement monitoring in pituitary disease.
For hyperthyroidism, free T4 and free T3 often improve before TSH recovers. Early treatment decisions therefore rely more on the thyroid hormones. Later, TSH becomes useful again. Persistently suppressed TSH after hormones normalize may reflect delayed recovery rather than continuing severe disease.
Pregnancy
Pregnancy changes TSH and thyroid hormone physiology. TSH often falls during the first trimester because human chorionic gonadotropin stimulates the thyroid. Reference intervals should be trimester and assay specific when available. Thyroid hormone requirements often increase early in pregnancy for people already taking levothyroxine. Prompt testing is important because maternal thyroid hormone supports fetal development.
Older adults
TSH tends to shift upward with age in many populations. A small elevation in an older adult may not carry the same meaning or treatment threshold as it does in pregnancy or a young adult. Overreplacement can increase the risk of atrial fibrillation and bone loss, so dose changes should be cautious.
Children and newborns
Thyroid hormone is essential for brain development and growth. Newborn screening commonly measures TSH, T4, or both, depending on the program. TSH-only screening can miss some central congenital hypothyroidism. Pediatric reference intervals vary by age, and delayed growth or puberty may require both thyroid and pituitary assessment.
Hospitalized and critically ill patients
Severe illness can lower T3, alter free T4, and suppress or transiently raise TSH. Glucocorticoids and dopamine can further suppress TSH. Unless thyroid dysfunction is strongly suspected, repeating tests after recovery may provide a clearer answer. A profoundly abnormal pattern with compatible symptoms still requires urgent evaluation.
Follow-up and urgent symptoms
An abnormal TSH usually leads to a focused next step rather than an immediate diagnosis. The clinician may repeat TSH and free T4, add free T3, check thyroid antibodies, review medicine timing and adherence, or investigate pituitary function. Comparison with previous results is valuable because a stable personal pattern differs from a rapid change.
Bring the complete laboratory report to review. The number, unit, reference interval, collection time, pregnancy status, thyroid dose timing, supplements, and recent illness all affect interpretation. Avoid adjusting thyroid medicine in response to one result without clinical guidance.
Further pituitary evaluation is appropriate when free T4 is low but TSH is not appropriately high, when several pituitary hormones are abnormal, or when symptoms include headache, visual-field loss, excessive thirst, amenorrhea, low testosterone, or poor lactation. MRI is ordered to answer a structural question after biochemical patterns have been checked.
Seek urgent care for symptoms of severe thyroid or pituitary decompensation. Warning signs include:
- Confusion, extreme drowsiness, low body temperature, slowed breathing, or severe weakness, which may occur in myxedema coma
- High fever, marked agitation, vomiting, severe diarrhea, rapid or irregular heartbeat, or heart failure symptoms, which may occur in thyroid storm
- Sudden severe headache, vision loss, double vision, fainting, or vomiting, which may indicate pituitary apoplexy
- Low blood pressure, abdominal pain, persistent vomiting, profound weakness, or collapse in someone with possible ACTH deficiency, which may indicate adrenal crisis
These emergencies are uncommon, but treatment should not wait for routine outpatient interpretation. For nonurgent abnormalities, a repeat and paired-hormone approach usually provides more information than chasing TSH alone.
The safest interpretation uses the paired pattern and the clinical setting rather than a single target number.
References
- TSH (Thyroid-stimulating hormone) Test 2024 (Official Medical Test Guide)
- Thyroxine (T4) Test 2024 (Official Medical Test Guide)
- Central Hypothyroidism: Advances in Etiology, Diagnostic Challenges, Therapeutic Targets, and Associated Risks 2025 (Review)
- Thyrotropin-Secreting Pituitary Adenomas 2025 (Review)
- 2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action 2024 (Guideline)
- Thyrotropin-secreting tumor “TSH-PitNET”: From diagnosis to treatment 2023 (Review)
Disclaimer
TSH results should be interpreted with the laboratory range, free T4, symptoms, medicines, pregnancy status, and any history of pituitary disease. Do not start, stop, or change thyroid or pituitary medication based on one result without medical guidance. Seek urgent care for severe confusion, high fever with a rapid heartbeat, sudden vision change, collapse, or a sudden severe headache.
